Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
130.90    0.60 (0.46%)
Bid:
130.90
Ask:
133.00
Spread: 2.10 (1.604%)
Market Cap: £1.27b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Directorate Change

29 Feb 2024 18:00

RNS Number : 0548F
Oxford Nanopore Technologies plc
29 February 2024
 

29 February 2024

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Directorate Change

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore-based molecular sensing technology, today announces the retirement of three Directors from the Board: Dr James ("Spike") Willcocks, Clive Brown, and Tim Cowper. Clive will step off the Board with immediate effect while Spike and Tim will not stand for re-election at the 2024 AGM and will retire from the Board at the conclusion of the AGM in June 2024. All three Directors will remain in their operational leadership roles at Oxford Nanopore: Spike as Chief Strategy Officer, Clive as Chief Technology, Innovation and Product Officer and Tim as Chief Operating Officer. Each will also continue to serve on the Company's Operating Committee.

These changes are part of normal Board evolution and in line with best practice governance.

Spike has served on the Board for 18 years and Clive and Tim have each served for five years.

Duncan Tatton-Brown, Chair of Oxford Nanopore, commented: "I would like to thank Spike, Clive and Tim for their outstanding support and contribution to the Board during their long tenure and specifically in the transition period since IPO. They have played a foundational role in building this Company, and we are grateful for their ongoing dedication and leadership."

As before and in line with the Company's delegation of authority, the Company has determined that only Directors are Persons Discharging Managerial Responsibilities (PDMRs). Following retirement from the Board, Clive, Spike and Tim will no longer be PDMRs.

Oxford Nanopore is committed to Board diversity, and this evolution will also progress towards fulfilling the Company's goal of reaching 40% female Board representation. Following the AGM, the Board will include two executive Directors and seven non-executive Directors, three of whom are women.

This announcement is made pursuant to Listing Rule 9.6.11R.

 

[ENDS]

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors: ir@nanoporetech.com

Media: media@nanoporetech.com

 

Teneo

Tom Murray, Olivia Peters

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUBCPUPCGMB
Date   Source Headline
4th Jun 20262:30 pmRNSResult of AGM
1st Jun 20264:00 pmRNSIssue of Equity and Total Voting Rights
21st May 20267:01 amRNSLondon Calling Technology Update
21st May 20267:00 amRNSOxford Nanopore strengthens executive team
13th May 20263:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSIssue of Equity and Total Voting Rights
1st May 20267:00 amRNSPublication of Annual Report and Notice of AGM
15th Apr 20265:30 pmRNSDirector/PDMR Shareholding - LTIP and DBP awards
14th Apr 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Apr 20263:00 pmRNSDirector/PDMR Shareholding - LTIP and DBP awards
1st Apr 20263:00 pmRNSIssue of Equity and Total Voting Rights
26th Mar 20263:00 pmRNSBlock Admission Application
4th Mar 20267:00 amRNS-RUpcoming Investor Events and Conferences
3rd Mar 20264:00 pmRNSGrant of LTIP awards; Director/PDMR Notification
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20264:00 pmRNSIssue of Equity and Total Voting Rights
2nd Mar 20267:00 amRNSAnnual results for the year ended 31 December 2025
27th Feb 20263:00 pmRNSUpdate on legal action against MGI Australia
27th Feb 20261:30 pmRNSDirector Declaration - John O'Higgins
12th Feb 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Feb 20263:00 pmRNSIssue of Equity and Total Voting Rights
14th Jan 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
7th Jan 20267:00 amRNS-RUpcoming Investor Events and Conferences
2nd Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
12th Dec 20253:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
8th Dec 20259:00 amRNSAGM Post-Meeting Shareholder Engagement Update
8th Dec 20257:00 amRNSAppointment of Francis Van Parys as CEO
1st Dec 20254:00 pmRNSIssue of Equity and Total Voting Rights
27th Nov 20257:00 amRNS-RUpcoming investor conferences
12th Nov 20254:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
7th Nov 20259:00 amRNSONT postpones investor event; reaffirms guidance
3rd Nov 20253:00 pmRNSIssue of Equity and Total Voting Rights
16th Oct 20257:00 amRNS-RUpcoming Investor Conferences and Events
14th Oct 20254:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
6th Oct 20255:30 pmRNSBlock listing Interim Review
1st Oct 20254:00 pmRNSIssue of Equity and Total Voting Rights
12th Sep 20254:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Sep 20257:00 amRNSInterim results for the 6 months ended 30 June 25
1st Sep 20255:00 pmRNSIssue of Equity and Total Voting Rights
13th Aug 20254:00 pmRNSShare Incentive Plan - Director/PDMR Notification
11th Aug 20257:00 amRNSChief Executive Officer Succession
8th Aug 20257:00 amRNSResult of Audit Tender
6th Aug 20257:00 amRNSCommencement of legal action against MGI Australia
1st Aug 20254:30 pmRNSIssue of Equity and Total Voting Rights
29th Jul 20257:00 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
14th Jul 20256:00 pmRNSShare Incentive Plan - Director/PDMR Notification
4th Jul 20254:30 pmRNS-RPublication of 2024 Sustainability Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.